Biohaven, Pfizer Get Positive CHMP Opinion For Rimegepant To Treat Migraine
25/2 14:00
(RTTNews) - Biohaven Pharmaceutical Holding Company Ltd. (BHVN), and Pfizer Inc. (PFE), said on Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA, has given a positive opinion for Rimegepant, for marketing authorization...